Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs
LONDON, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Autolus plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical firm growing next-generation programmed T ...
